Final results of a phase III randomized study of concurrent weekly cisplatin-RT versus RT alone in locoregionally advanced nasopharyngeal carcinoma (NPC).

被引：0
|
作者：
Chan, AT
Ngan, R
Teo, P
Leung, SF
Yiu, HY
Yeo, W
Mok, T
Cheung, FY
Kwan, W
Zee, B
机构：
[1] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
[2] Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5523
引用
收藏
页码：493S / 493S
页数：1
相关论文
共 50 条
  • [31] Locoregionally advanced nasopharyngeal carcinoma:: Induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin -: A phase II study
    Ferrari, D.
    Chiesa, F.
    Codeca, C.
    Calabrese, L.
    Jereczek-Fossa, B. A.
    Alterio, D.
    Fiore, J.
    Luciani, A.
    Floriani, I.
    Orecchia, R.
    Foa, P.
    ONCOLOGY, 2008, 74 (3-4) : 158 - 166
  • [32] A phase II study of concurrent cetuximab-cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma
    Ma, B. B. Y.
    Kam, M. K. M.
    Leung, S. F.
    Hui, E. P.
    King, A. D.
    Chan, S. L.
    Mo, F.
    Loong, H.
    Yu, B. K. H.
    Ahuja, A.
    Chan, A. T. C.
    ANNALS OF ONCOLOGY, 2012, 23 (05) : 1287 - 1292
  • [33] Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Progression-free survival analysis of a phase III randomized trial
    Chan, ATC
    Teo, PML
    Ngan, RK
    Leung, TW
    Lau, WH
    Zee, B
    Leung, SF
    Cheung, FY
    Yeo, W
    Yiu, HH
    Yu, KH
    Chiu, KW
    Chan, DT
    Mok, T
    Yuen, KT
    Mo, F
    Lai, M
    Kwan, WH
    Choi, P
    Johnson, PJ
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (08) : 2038 - 2044
  • [34] Long term results of a randomized phase III study of nimotuzumab in combination with concurrent radiotherapy and cisplatin versus radiotherapy and cisplatin alone, in locally advanced squamous cell carcinoma of the head and neck.
    Patil, Vijay Maruti
    Noronha, Vanita
    Menon, Nandini Sharrel
    Shah, Minit Jalan
    Ghosh, Sarbani Laskar
    Budrukkar, Ashwini
    Swain, Monali
    Balaji, Arun
    Chaukar, Devendra
    Pai, Prathamesh S.
    Chaturvedi, Pankaj
    Prabhash, Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL) : LBA6092 - LBA6092
  • [35] Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis (vol 39, 40, 2019)
    Liao, Jun-Fang
    Zhang, Qun
    Du, Xiao-Jing
    Lan, Mei
    Liu, Shan
    Xia, Yun-Fei
    Cai, Xiu-Yu
    Luo, Wei
    CANCER COMMUNICATIONS, 2019, 39 (01):
  • [36] INDUCTION CHEMOTHERAPY PLUS CONCURRENT CHEMORADIOTHERAPY VERSUS CONCURRENT CHEMORADIOTHERAPY ALONE IN PATIENTS WITH LOCOREGIONALLY ADVANCED NASOPHARYNGEAL CARCINOMA: PRELIMINARY RESULTS OF A PHASE 3 MULTICENTRE RANDOMISED CONTROLLED TRIAL
    Ma, J.
    Chen, N. -Y.
    Zhang, N.
    Hu, G. -Q.
    Sun, Y.
    Chen, X. -Z.
    Li, J. -G.
    Zhu, X. -D.
    Hu, C. -S.
    Xu, X. -Y.
    Sun, Y.
    Xie, F. -Y.
    Hua, W. -H.
    Guo, L.
    Mo, H. -Y.
    Guo, Y.
    Chen, L.
    Li, W. -F.
    Liu, M. -Z.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : E3 - E4
  • [37] Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial
    Sun, Ying
    Li, Wen-Fei
    Chen, Nian-Yong
    Zhang, Ning
    Hu, Guo-Qing
    Xie, Fang-Yun
    Sun, Yan
    Chen, Xiao-Zhong
    Li, Jin-Gao
    Zhu, Xiao-Dong
    Hu, Chao-Su
    Xu, Xiang-Ying
    Chen, Yuan-Yuan
    Hu, Wei-Han
    Guo, Ling
    Mo, Hao-Yuan
    Chen, Lei
    Mao, Yan-Ping
    Sun, Rui
    Ai, Ping
    Liang, Shao-Bo
    Long, Guo-Xian
    Zheng, Bao-Min
    Feng, Xing-Lai
    Gong, Xiao-Chang
    Li, Ling
    Shen, Chun-Ying
    Xu, Jian-Yu
    Guo, Ying
    Chen, Yu-Ming
    Zhang, Fan
    Lin, Li
    Tang, Ling-Long
    Liu, Meng-Zhong
    Ma, Jun
    LANCET ONCOLOGY, 2016, 17 (11): : 1509 - 1520
  • [38] Induction chemotherapy regimen of docetaxel plus cisplatin vs docetaxel, cisplatin plus fluorouracil followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Preliminary results of a phase III multicenter randomized controlled trial
    He, S.
    Wang, Y.
    Wang, C.
    Peng, Z.
    Chen, Y.
    ANNALS OF ONCOLOGY, 2022, 33 : S1521 - S1521
  • [39] Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy
    Wee, Chan Woo
    Keam, Bhumsuk
    Heo, Dae Seog
    Sung, Myung-Whun
    Won, Tae-Bin
    Wu, Hong-Gyun
    RADIATION ONCOLOGY JOURNAL, 2015, 33 (02): : 98 - 108
  • [40] TIRA study: A phase III, multicenter, randomized controlled study of toripalimab plus radical chemoradiotherapy with or without concurrent cisplatin in patients with high-risk locoregionally advanced nasopharyngeal carcinoma.
    Xu, Cheng
    Ma, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345